Effects of Cardiac Rehabilitation on High Mobility Group Box-1 Levels After Acute Myocardial Infarction
This study has been completed.
Sponsor:
Federico II University
Information provided by:
Federico II University
ClinicalTrials.gov Identifier:
NCT00755131
First received: September 17, 2008
Last updated: January 25, 2010
Last verified: December 2009
- Full Text View
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Results First Received: November 5, 2009
| Study Type: | Interventional |
|---|---|
| Study Design: | Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: Single Blind (Investigator); Primary Purpose: Basic Science |
| Condition: |
Acute Myocardial Infarction |
| Intervention: |
Other: Exercise-based Cardiac Rehabilitation program |
Participant Flow
Recruitment Details
| Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations |
|---|
| This study was a single-center, randomized, controlled study carried out from October 2008 to January 2009 at the Department of Clinical Medicine, Cardiovascular and Immunological Sciences, University of Naples “Federico II”. |
Pre-Assignment Details
| Significant events and approaches for the overall study following participant enrollment, but prior to group assignment |
|---|
| No text entered. |
Reporting Groups
| Description | |
|---|---|
| Exercise Training Group | Postinfarction patients undergoing 6-month exercise-based Cardiac Rehabilitation Program |
| Control Group | Postinfarction patients NOT enrolled in exercise-based Cardiac Rehabilitation program. |
Participant Flow: Overall Study
| Exercise Training Group | Control Group | |
|---|---|---|
| STARTED | 37 | 38 |
| COMPLETED | 37 | 38 |
| NOT COMPLETED | 0 | 0 |
Baseline Characteristics
Reporting Groups
| Description | |
|---|---|
| Exercise Training Group | Postinfarction patients undergoing 6-month exercise-based Cardiac Rehabilitation Program |
| Control Group | Postinfarction patients NOT enrolled in exercise-based Cardiac Rehabilitation program. |
| Total | Total of all reporting groups |
Baseline Measures
| Exercise Training Group | Control Group | Total | |
|---|---|---|---|
|
Number of Participants
[units: participants] |
37 | 38 | 75 |
|
Age
[units: participants] |
|||
| <=18 years | 0 | 0 | 0 |
| Between 18 and 65 years | 28 | 29 | 57 |
| >=65 years | 9 | 9 | 18 |
|
Age
[units: years] Mean ± Standard Deviation |
60.8 ± 7.0 | 59.5 ± 7.7 | 60.4 ± 7.5 |
|
Gender
[units: participants] |
|||
| Female | 9 | 6 | 15 |
| Male | 28 | 32 | 60 |
|
Region of Enrollment
[units: participants] |
|||
| Italy | 37 | 38 | 75 |
Outcome Measures
| 1. Primary: | High Mobility Group Box-1 (HMGB1)Levels at Baseline and 6 Months [ Time Frame: baseline and 6-month follow-up ] |
| Measure Type | Primary |
|---|---|
| Measure Title | High Mobility Group Box-1 (HMGB1)Levels at Baseline and 6 Months |
| Measure Description | High mobility group box-1 (HMGB1) is a ubiquitous nuclear protein, constitutively expressed in quiescent cells, where it is involved in several cellular functions, including determination of nucleosomal structure and stability, and binding of transcription factors to DNA sequences. HMGB1 has been recently recognized as a critical mediator of inflammatory processes: the passive release of this protein from necrotic or damaged cells represents an effective stimulus triggering the inflammatory response. |
| Time Frame | baseline and 6-month follow-up |
| Safety Issue | No |
Population Description
| Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate. |
|---|
| No text entered. |
Reporting Groups
| Description | |
|---|---|
| Exercise Training Group | Postinfarction patients undergoing 6-month exercise-based Cardiac Rehabilitation Program |
| Control Group | Postinfarction patients NOT enrolled in exercise-based Cardiac Rehabilitation program. |
Measured Values
| Exercise Training Group | Control Group | |
|---|---|---|
|
Number of Participants Analyzed
[units: participants] |
37 | 38 |
|
High Mobility Group Box-1 (HMGB1)Levels at Baseline and 6 Months
[units: ng/ml] Mean ± Standard Deviation |
||
| Baseline | 27.6 ± 27.8 | 24.5 ± 18.6 |
| 6 months | 11.7 ± 7.0 | 20.5 ± 15.6 |
Statistical Analysis 1 for High Mobility Group Box-1 (HMGB1)Levels at Baseline and 6 Months
| Groups [1] | All groups |
|---|---|
| Method [2] | t-test, 2 sided |
| P Value [3] | <0.05 |
| [1] | Additional details about the analysis, such as null hypothesis and power calculation: |
|---|---|
| Sample size determination was based on a t-test assuming a normal distribution with non-equal variance with the mean and standard deviation for the experimental group (postinfarction patients) of HMGB1 levels equal to 15 ± 7 and 2 ± 1 ng/dl for the control group derived from a previous study, respectively. The required sample size was calculated to be 30 subjects per group to detect on the size of one SD with α value of 0.05 (two-sided) and power (1 – β) of 0.8. | |
| [2] | Other relevant information, such as adjustments or degrees of freedom: |
| No text entered. | |
| [3] | Additional information, such as whether or not the p-value is adjusted for multiple comparisons and the a priori threshold for statistical significance: |
| No text entered. |
| 2. Secondary: | Peak Oxygen Consumption (VO2peak) at Baseline and 6 Months [ Time Frame: Baseline and 6-month follow-up ] |
| Measure Type | Secondary |
|---|---|
| Measure Title | Peak Oxygen Consumption (VO2peak) at Baseline and 6 Months |
| Measure Description | Oxygen consumption at peak exercise stress testing (VO2peak) was obtained breath-by-breath with use of a computerized metabolic cart. VO2peak was recorded as the mean value of VO2 during the last 20 s of the test and expressed in millilitres per kilogram per minute. |
| Time Frame | Baseline and 6-month follow-up |
| Safety Issue | No |
Population Description
| Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate. |
|---|
| intention to treat (ITT) analysis |
Reporting Groups
| Description | |
|---|---|
| Exercise Training Group | Postinfarction patients undergoing 6-month exercise-based Cardiac Rehabilitation Program |
| Control Group | Postinfarction patients NOT enrolled in exercise-based Cardiac Rehabilitation program. |
Measured Values
| Exercise Training Group | Control Group | |
|---|---|---|
|
Number of Participants Analyzed
[units: participants] |
37 | 38 |
|
Peak Oxygen Consumption (VO2peak) at Baseline and 6 Months
[units: ml/kg/min] Mean ± Standard Deviation |
||
| baseline | 16.4 ± 1.5 | 16.7 ± 2.2 |
| 6 months | 21.0 ± 2.4 | 16.3 ± 1.8 |
Statistical Analysis 1 for Peak Oxygen Consumption (VO2peak) at Baseline and 6 Months
| Groups [1] | All groups |
|---|---|
| Method [2] | t-test, 2 sided |
| P Value [3] | <0.05 |
| [1] | Additional details about the analysis, such as null hypothesis and power calculation: |
|---|---|
| No text entered. | |
| [2] | Other relevant information, such as adjustments or degrees of freedom: |
| No text entered. | |
| [3] | Additional information, such as whether or not the p-value is adjusted for multiple comparisons and the a priori threshold for statistical significance: |
| No text entered. |
| 3. Other Pre-specified: | Heart Rate Recovery at Baseline and 6 Months [ Time Frame: baseline and 6 month follow-up ] |
| Measure Type | Other Pre-specified |
|---|---|
| Measure Title | Heart Rate Recovery at Baseline and 6 Months |
| Measure Description |
The autonomic nervous system (ANS) is the part of the peripheral nervous system that acts as a control system functioning largely below the level of consciousness, and controls visceral functions. It is subdivided into two subsystems: the parasympathetic (vagal) and sympathetic nervous system. Sympatho-vagal imbalance is evaluated by post-exercise Heart Rate Recovery (HRR), defined as the fall in heart rate during the first minute after exercise (beats/min). HRR is a marker of vagal tone which is a powerful predictor of all-cause mortality in patients with coronary artery disease. |
| Time Frame | baseline and 6 month follow-up |
| Safety Issue | No |
Population Description
| Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate. |
|---|
| No text entered. |
Reporting Groups
| Description | |
|---|---|
| Exercise Training Group | Postinfarction patients undergoing 6-month exercise-based Cardiac Rehabilitation Program |
| Control Group | Postinfarction patients NOT enrolled in exercise-based Cardiac Rehabilitation program. |
Measured Values
| Exercise Training Group | Control Group | |
|---|---|---|
|
Number of Participants Analyzed
[units: participants] |
37 | 38 |
|
Heart Rate Recovery at Baseline and 6 Months
[units: beats/min] Mean ± Standard Deviation |
||
| baseline | 13.4 ± 1.7 | 13.8 ± 2.7 |
| 6 months | 19.7 ± 3.4 | 12.4 ± 2.5 |
Statistical Analysis 1 for Heart Rate Recovery at Baseline and 6 Months
| Groups [1] | All groups |
|---|---|
| Method [2] | t-test, 2 sided |
| P Value [3] | <0.05 |
| [1] | Additional details about the analysis, such as null hypothesis and power calculation: |
|---|---|
| No text entered. | |
| [2] | Other relevant information, such as adjustments or degrees of freedom: |
| No text entered. | |
| [3] | Additional information, such as whether or not the p-value is adjusted for multiple comparisons and the a priori threshold for statistical significance: |
| No text entered. |
More Information
Certain Agreements:
Limitations and Caveats
Results Point of Contact:
Publications:
Publications automatically indexed to this study:
| All Principal Investigators ARE employed by the organization sponsoring the study. |
Limitations and Caveats
| Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data |
|---|
| No text entered. |
Results Point of Contact:
Name/Title: Prof. Carlo Vigorito, Director Cardiac Rehabilitation Unit, Federico II University
Organization: University of Naples Federico II
phone: +39081746 ext 2639
e-mail: vigorito@unina.it
Organization: University of Naples Federico II
phone: +39081746 ext 2639
e-mail: vigorito@unina.it
Publications:
Publications automatically indexed to this study:
| Responsible Party: | Carlo Vigorito, Department of Clinical Medicine, Cardiovascular and Immunological Sciences |
| ClinicalTrials.gov Identifier: | NCT00755131 History of Changes |
| Other Study ID Numbers: | UNINA-15775 |
| Study First Received: | September 17, 2008 |
| Results First Received: | November 5, 2009 |
| Last Updated: | January 25, 2010 |
| Health Authority: | Italy: National Institute of Health |